We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.14%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$99.1B
AUM Growth
+$7.92B
Cap. Flow
+$3.27B
Cap. Flow %
3.3%
Top 10 Hldgs %
23.39%
Holding
4,186
New
432
Increased
2,037
Reduced
1,399
Closed
199

Sector Composition

Rank Sector Weight
1 Technology 14%
2 Financials 8.86%
3 Healthcare 8.09%
4 Industrials 6.83%
5 Consumer Discretionary 6.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OXSQ icon
3751
Oxford Square Capital
OXSQ
$151M
$107K ﹤0.01%
23,122
-1,735
-7% -$6.75K
GNPX icon
3752
Genprex
GNPX
$2.26M
$106K ﹤0.01%
1
RTL
3753
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$106K ﹤0.01%
10,766
-4,882
-31% -$42.5K
X
3754
CALL
DELISTED
US Steel
X
$105K ﹤0.01%
19,300
+5,700
+42% +$113K
CMU
3755
DELISTED
MFS High Yield Municipal Trust
CMU
$104K ﹤0.01%
23,415
LITS
3756
Lite Strategy Inc
LITS
$30.7M
$103K ﹤0.01%
1,496
PHK
3757
PIMCO High Income Fund
PHK
$875M
$103K ﹤0.01%
15,226
-2,625
-15% -$16.5K
ENB icon
3758
CALL
Enbridge
ENB
$113B
$101K ﹤0.01%
44,900
+600
+1% +$21.1K
MIN
3759
Aberdeen Intermediate Income Fund
MIN
$280M
$101K ﹤0.01%
27,281
-17,311
-39% -$64.9K
DOW icon
3760
CALL
Dow Inc
DOW
$22.6B
$100K ﹤0.01%
28,800
-12,300
-30% -$736K
FPAC
3761
DELISTED
Far Peak Acquisition Corporation
FPAC
$100K ﹤0.01%
+10,200
New +$105K
DUK icon
3762
CALL
Duke Energy
DUK
$96.1B
$99K ﹤0.01%
+32,000
New +$2.92M
RUN icon
3763
CALL
Sunrun
RUN
$2.42B
$99K ﹤0.01%
+20,600
New +$1.43M
AUY
3764
DELISTED
Yamana Gold, Inc.
AUY
$98K ﹤0.01%
22,644
-708,323
-97% -$3.38M
CLVS
3765
DELISTED
Clovis Oncology, Inc.
CLVS
$98K ﹤0.01%
+13,897
New +$93.2K
AAOI icon
3766
Applied Optoelectronics
AAOI
$11.4B
$97K ﹤0.01%
11,570
-950
-8% -$9.54K
CARM
3767
DELISTED
Carisma Therapeutics
CARM
$97K ﹤0.01%
+1,870
New +$88.2K
CNDT icon
3768
Conduent
CNDT
$245M
$96K ﹤0.01%
14,388
-868
-6% -$4.95K
YARW
3769
Yarrow Bioscience, Inc. Common Stock
YARW
$115M
$95K ﹤0.01%
15
CB icon
3770
CALL
Chubb
CB
$134B
$94K ﹤0.01%
52,100
+17,700
+51% +$2.85M
SCYX icon
3771
SCYNEXIS
SCYX
$48M
$94K ﹤0.01%
1,474
+114
+8% +$7.48K
TBLT
3772
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
$94K ﹤0.01%
+10
New +$117K
VIEW
3773
DELISTED
View, Inc. Class A Common Stock
VIEW
$91K ﹤0.01%
+206
New +$128K
HEXO
3774
DELISTED
HEXO Corp. Common Shares
HEXO
$90K ﹤0.01%
+997
New +$97.1K
CMA
3775
CALL
DELISTED
Comerica
CMA
$89K ﹤0.01%
+38,000
New +$2.49M

Similar funds

Raymond James & Associates's Q1 2021 Portfolio in Review

As of Q1 2021, Raymond James & Associates held 4,186 positions worth $99.1B, up 8.7% from $91.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates deployed $3.27B of net new capital in Q1 2021, opening 432 new positions and adding to 2,037 existing holdings. Its largest new stake was BlackRock Technology and Private Equity Term Trust: 1,676,875 shares worth $34M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard High Dividend Yield ETF, an estimated $671M trimmed.

  • Raymond James & Associates's largest Q1 2021 buy was BlackRock Technology and Private Equity Term Trust: 1,676,875 shares worth $34M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2021, an estimated $1.36B increase.
  • Raymond James & Associates's biggest Q1 2021 reduction was Vanguard High Dividend Yield ETF, cutting an estimated $671M.
  • Raymond James & Associates fully exited Sensient Technologies in Q1 2021, selling an estimated $15.6M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $99.1B portfolio in Q1 2021.
  • Raymond James & Associates opened 432 new positions and closed 199 in Q1 2021.
  • Raymond James & Associates's portfolio value rose 8.7% quarter-over-quarter to $99.1B.

Based on Raymond James & Associates's 13F filing for Q1 2021, filed 14 May 2021.